OBJECTIVE: To explore the critical value and possible influencing factors of fractional exhaled nitric oxide (FeNO) in suspected asthma patients. METHODS: 923 suspected asthmatics consecutively referred to our hospital during December 2012 to July 2014 were selected. All cases were carried out FeNO measurement at first; next, spirometry, bronchoprovocation tests or bronchodilation tests were used to confirm or exclude asthma. Receiver operating characteristic curve (ROC) was used to determine the best cut-off value of FeNO for asthma diagnosis. RESULTS: In bronchoprovocation test, 125 cases were diagnosed as asthma, other 283 were non-asthmatics. FeNO levels of asthmatics were significantly higher than non-asthmatics (median, 64.8 ppb vs. 27.9 ppb, P<0.01). In this group of patients, 64 ppb was the best cut-off value of FeNO to identify asthma with sensitivity of 52.0% and specificity of 94.35%. In bronchodilation test, 185 patients were diagnosed as asthma, other 330 were non-asthmatics. FeNO levels of asthmatics were significantly higher than non-asthmatics (median, 60.6 ppb vs. 29.05 ppb, P<0.01). In bronchodilation test patients, 41 ppb was the best cut-off value of FeNO to identify asthma with sensitivity of 72.43% and specificity of 74.85%. Influencing factors analysis showed that sex was an independent factor affecting patients' FeNO level. CONCLUSION: FeNO was an effective auxiliary diagnosis method for bronchial asthma. 64 ppb and 41 ppb was the best cut-off value of FeNO to identify asthma in bronchoprovocation test or bronchodilation test, respectively. Sex was an independent factor affecting patients' FeNO level.
OBJECTIVE: To explore the critical value and possible influencing factors of fractional exhaled nitric oxide (FeNO) in suspected asthmapatients. METHODS: 923 suspected asthmatics consecutively referred to our hospital during December 2012 to July 2014 were selected. All cases were carried out FeNO measurement at first; next, spirometry, bronchoprovocation tests or bronchodilation tests were used to confirm or exclude asthma. Receiver operating characteristic curve (ROC) was used to determine the best cut-off value of FeNO for asthma diagnosis. RESULTS: In bronchoprovocation test, 125 cases were diagnosed as asthma, other 283 were non-asthmatics. FeNO levels of asthmatics were significantly higher than non-asthmatics (median, 64.8 ppb vs. 27.9 ppb, P<0.01). In this group of patients, 64 ppb was the best cut-off value of FeNO to identify asthma with sensitivity of 52.0% and specificity of 94.35%. In bronchodilation test, 185 patients were diagnosed as asthma, other 330 were non-asthmatics. FeNO levels of asthmatics were significantly higher than non-asthmatics (median, 60.6 ppb vs. 29.05 ppb, P<0.01). In bronchodilation test patients, 41 ppb was the best cut-off value of FeNO to identify asthma with sensitivity of 72.43% and specificity of 74.85%. Influencing factors analysis showed that sex was an independent factor affecting patients' FeNO level. CONCLUSION:FeNO was an effective auxiliary diagnosis method for bronchial asthma. 64 ppb and 41 ppb was the best cut-off value of FeNO to identify asthma in bronchoprovocation test or bronchodilation test, respectively. Sex was an independent factor affecting patients' FeNO level.
Authors: Christiane Lex; Flavia Ferreira; Angela Zacharasiewicz; Andrew G Nicholson; Patricia L Haslam; Nicola M Wilson; Trevor T Hansel; Donald N R Payne; Andrew Bush Journal: Am J Respir Crit Care Med Date: 2006-09-14 Impact factor: 21.405
Authors: Z Zietkowski; A Bodzenta-Lukaszyk; M M Tomasiak; R Skiepko; M Szmitkowski Journal: J Investig Allergol Clin Immunol Date: 2006 Impact factor: 4.333
Authors: Mario Olivieri; Giorgio Talamini; Massimo Corradi; Luigi Perbellini; Antonio Mutti; Claudio Tantucci; Mario Malerba Journal: Respir Res Date: 2006-06-30
Authors: Antonius Schneider; Lisa Tilemann; Tjard Schermer; Lena Gindner; Gunter Laux; Joachim Szecsenyi; Franz Joachim Meyer Journal: Respir Res Date: 2009-03-03
Authors: D Robin Taylor; Piush Mandhane; Justina M Greene; Robert J Hancox; Sue Filsell; Christene R McLachlan; Avis J Williamson; Jan O Cowan; Andrew D Smith; Malcolm R Sears Journal: Respir Res Date: 2007-11-15